Basic information Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Bromopyridine >  3-BroMo-5fluoro-4-Methylpyridine

3-BroMo-5fluoro-4-Methylpyridine

Basic information Uses Safety Supplier Related

3-BroMo-5fluoro-4-Methylpyridine Basic information

Product Name:
3-BroMo-5fluoro-4-Methylpyridine
Synonyms:
  • 3-BroMo-5fluoro-4-Methylpyridine
  • Pyridine, 3-bromo-5-fluoro-4-methyl-
  • 3-BroMo-5fluoro-4-Methylpyridine ISO 9001:2015 REACH
CAS:
1211517-76-8
MF:
C6H5BrFN
MW:
190.01
Mol File:
1211517-76-8.mol
More
Less

3-BroMo-5fluoro-4-Methylpyridine Chemical Properties

Boiling point:
183.5±35.0 °C(Predicted)
Density 
1.592±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
pka
1.11±0.28(Predicted)
form 
liquid
color 
Clear, colourless
More
Less

Safety Information

HS Code 
2933399990
More
Less

3-BroMo-5fluoro-4-Methylpyridine Usage And Synthesis

Uses

3-Bromo-5-fluoro-4-methylpyridine is a heterocyclic organic compound that can be used as an organic chemical intermediate and can be obtained by methylation of 3-bromo-5-fluoropyridine.

Synthesis

407-20-5

74-88-4

1211517-76-8

Step 1: Dissolve 3-bromo-5-fluoropyridine (5.0 g, 28.4 mmol) in anhydrous THF (23 mL) at -78 °C and slowly dropwise add LDA (2M solution of cyclohexane/ethylphenol THF, 21.3 mL, 42.6 mmol) to the solution of anhydrous THF (23 mL), with the dropwise addition time being controlled to be within 10 minutes. After dropwise addition, stirring was continued at -78 °C for 30 min. Subsequently, a solution of anhydrous THF (23 mL) in iodomethane (2.6 mL, 42.6 mmol) was slowly added dropwise, and after completion of dropwise addition, stirring was continued at -78 °C for 30 min. The reaction mixture was warmed to room temperature and stirred for 2 h. Upon completion of the reaction, the reaction was quenched with saturated NaHCO3 solution. NH4Cl solution was added and after stirring for 30 minutes at room temperature, the reaction mixture was extracted with EtOAc. The organic layers were combined, dried and concentrated under reduced pressure, and the residue was purified by column chromatography (SiO2, EtOAc/cyclohexane) to afford the target product 3-bromo-4-methyl-5-fluoropyridine (3.6 g, 66% yield).

References

[1] Patent: WO2015/22073, 2015, A1. Location in patent: Page/Page column 49
[2] Patent: US2013/109720, 2013, A1. Location in patent: Paragraph 0092; 0093
[3] Patent: WO2012/12478, 2012, A1. Location in patent: Page/Page column 48-49
[4] Patent: WO2012/148808, 2012, A1. Location in patent: Page/Page column 49
[5] Patent: WO2013/43520, 2013, A1. Location in patent: Page/Page column 36

3-BroMo-5fluoro-4-MethylpyridineSupplier

Zhuhai Aobokai Biomedical Technology Co., Ltd. Gold
Tel
400-0628126
Email
sales-team@aobchem.com.cn
Accela ChemBio Co.,Ltd.
Tel
021-50795510 4000665055
Email
sales@accelachem.com
Santai Labs, Inc.
Tel
519-85601385
Email
marketing@santailabs.com
Shanghai AmasPharm Co., Ltd.
Tel
021-54540637 18621091017
Email
sales@amaspharm.com
ZhengZhou HuaWen Chemical Co.Ltd
Tel
0370-2785118 17550508557
Email
675141927@qq.com